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With the COVID-19 pandemic the relationship between science and warfare seems to have scaled up to a new level. In the 
current information war, science seems to be used as the weapon itself, instrumentalized by different parties featuring diverse 
vested interests with the aim to advance their agendas.
In such circumstances information may be manipulated in several ways. The paper ranks different forms of “persuasion” 
in ascending order, from paternalism to full-blown authoritarianism, as exemplified by various episodes during the COVID-19 
emergency. Finally, it advances some proposals regarding science policy approaches, in particular the development of virtuous 
mechanisms that reward overall public and individual health, instead of just reimbursing interventions (with the consequent 
spiral of increasing insurance costs). As Tallacchini (2019) underlines, authoritarianism and nudging are not the only possible 
routes to be explored. A third way is a new confidence pact between institutions, private sector and citizens, and a new Hippo-
cratic Oath between patients and doctors, fostered by the right mechanisms, both for the social planner and for the entrepreneur, 
in view of the long term wellbeing and welfare of the population. If  someone needs to be nudged, this is those who hold the 
power in the system of asymmetries characterizing complex societies, not the vulnerable, whom the State should defend from 
abuses of power, of any kind.
Key words: Scientific uncertainty, Evidence standards, Expert knowledge, Regulatory capture, Science tyranny, Epistemic 
asymmetries, Information wars, COVID-19.
Con la pandemia COVID-19 il rapporto tra scienza e guerra sembra aver subito un incremento di scala. Nell’attuale guerra delle in-
formazioni, la scienza sembra utilizzata come un’arma essa stessa; strumentalizzata dalle diverse parti in conflitto con interessi costituiti di 
varia natura, al fine di attuare la propria agenda. In tali circostanze l’informazione può essere manipolata in vari modi. L’articolo ordina in 
modo ascendente queste forme di “persuasione” a partire dal paternalismo, fino a espressioni dittatoriali a tutti gli effetti, esemplificate da 
vari episodi accaduti durante l’emergenza COVID-19. Infine si avanzano alcune proposte relative alla politica della scienza, in particolare 
verso lo sviluppo di meccanismi virtuosi che premino la salute pubblica e individuale nel suo complesso, invece di rimborsare interventi (con 
la relativa spirale di crescita dei costi assicurativi). Come sottolineato da Tallacchini (2019), autoritarismo e “nudging” non sono le uniche 
possibilità da esplorare. Una terza via può essere quella di un patto di fiducia tra istituzioni, settore privato e cittadini, e un nuovo giuramen-
to ippocratico promosso dai meccanismi regolatori che incentivino sia il pianificatore sociale che l’imprenditore a migliorare il benessere 
della popolazione e il welfare. Se c’è qualcuno a cui vanno rivolte le politiche di “nudging”, questi è colui che detiene le leve del potere nel 
sistema di asimmetrie caratteristico delle società complesse, non 
chi si trova in posizione di vulnerabilità, che invece lo Stato è chia-
mato a difendere da abusi di potere, di qualsiasi tipo. 
Parole chiave: Incertezza scientifica, Standard di prova, 
Conoscenza degli esperti, Acquisizione normativa, Tirannia 
scientifica, Asimmetrie epistemiche, Guerre informative, COV-
ID-19.
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Introduction
Science and warfare have always been having a tight 
relationship, unfortunately. That the pursuit of truth bears 
with it the negative externality of mass destruction and death 
seems paradoxical, but a deeper look just reveals the Janus 
character of any human activity and social institution.
With the COVID-19 pandemic however, this relationship 
seems to have scaled up to a new level. Whereas until now 
science had been the instrument for producing more and 
more sophisticated technologies for defense and attack; in 
the current information war, science seems to be used as the 
weapon itself, instrumentalized by different parties featuring 
diverse vested interests with the aim to advance their agen-
das, obviously not necessarily to the benefit of the citizen, 
or humanity. The citizen, overwhelmed by an unmanagea-
ble quantity of fragmented and contradictory information, 
and at the same time oppressed by the severe limitation 
of elementary human rights through various measures of 
lockdown and confinement, is baffled by the uncertain mid 
and long term economic and social prospects of the epide-
mic. All the more, since scientific uncertainty both affects the 
estimation of such prospects and undermines the epidemics 
mitigation measures.
Such uncertainty is exacerbated by the awareness that 
knowledge producers themselves have vested interests, and 
by the fact that policy makers, if  “captured” by lobbyists and 
interest groups, may become biased social planners: i.e., they 
may not act in the interest of the population, but rather re-
flect the aims of interest groups and ideological movements 
in direct contrast with the normal democratic functioning of 
the Res Pubblica. 
Reliance on task forces of experts does not solve the is-
sue, but rather aggravates it: 1) bias is only shifted one step 
further: experts might represent on their turn specific inte-
rest groups and steer the social planner towards policies that 
benefit their own agenda rather than the public wellbeing; 
2) being non-democratically elected, experts are even less 
accountable towards the population, than policy-makers 
themselves, and may serve the purpose of buck-passing the 
blameworthiness for unwelcome measures. 
In issues of Science and Technology, policy-makers 
may be (unconsciously) “captured” because of the intrinsic 
opacity of scientific knowledge. This phenomenon may be 
exacerbated in cases where experts themselves are extremely 
insecure or in reciprocal contradiction, all the more if  they 
ask for legal immunity. In any case, the policy makers may be 
(perceived as) non-benevolent, and therefore untrustworthy, 
not only with regard to their decisions, but also with regard 
to the information they provide.
Indeed, in such circumstances information may be ma-
nipulated in several ways in order to persuade the receiver to 
act in one’s preferred way1. In a scale from weaker to stronger 
forms of “persuasion”, via using science and scientific uncer-
tainty, we can register the following (non-exhaustive) list of 
possibilities:
1. Paternalism: e.g. governmental and related official insti-
tutions are presented as the only reliable sources of infor-
mation for the right course of action (“They know best”);
2. Censorship and selective reporting: scientific information 
that goes against the governmental agenda is silenced; 
3. Exploiting and artificially inflating scientific uncertainty 
by disqualifying the reliability of  the source, methods or 
underpinning scientific theories that go against the go-
vernmental agenda;
 3.1. Double standards: raising or lowering methodolo-
gical standards depending on the evidence content and 
its implications for policy decisions;
 3.2. Disqualification of opponents’ theories without en-
tering into the subject, just by stigmatizing them as “con-
spirationist”;
 3.3. Blame Game (e.g. ad hominem arguments against 
scientists); 
4. Scientific propaganda: public relations activities and mo-
nopolization of the mainstream media agenda;
5. Scientific fraud: e.g. promoting the publication of fraudu-
lent studies in order to undermine opponents’ argumen-
tation and available evidence;
6. Authoritarianism:
 6.1.  “Scientific lockdown”: Suppression of scientific 
investigation (e.g. discouraging or prohibiting autopsies);
 6.2. Suppression/obstruction/delay of non-lucrative 
and therefore less preferred clinical practices (e.g. plasma 
therapy, hydroxychloroquine);
 6.3. Use of deaths in order to retaliate the opposition 
and silence it;
7. Malevolent social planning: enactment of malevolent po-
licies that are irrational from the point of view of the po-
pulation’s wellbeing in the short, medium or long term, 
because of more or less hidden agendas;
8. Information wars: violation of patency rights, classified 
research leakage;
9. Science tyranny: the “Therapeutic State”.
In the following we will give examples of such strategies 
and comment on their epistemological status and implica-
tions, by giving more emphasis to phenomena of epistemic 
interest. A discussion on their serious consequences conclu-
des the paper. 
1 The game-theoretic literature offers examples of such strategic in-
teractions in the sciences (see for instance (Hedlund, 2015, 2017; 
Felgenhauer and Loerke, 2017; Kamenica and Gentzkow, 2011; 
2016, 2017; Henry, 2009; Kolotilin, 2014; Herresthal, 2019).
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Paternalism
To start with an example of such science in trench, we 
analyse the divulgation activity on the COVID-19 pandemic 
by the popular virologist, Roberto Burioni (Professor of Mi-
crobiology and Virology at the Faculty of Medicine and Sur-
gery of the University Life-Health San Raffaele in Milan). 
His attitude toward the COVID-19 case has been rather vola-
tile, starting by fully excluding that the epidemic could reach 
Italy until the end of January, i.e. at a time when countenance 
measures – labeled as discriminatory against the Chinese pe-
ople by the Government and the WHO – could have possibly 
attenuated the impact of the epidemic in our country, and en-
ding with the full support of Draconian measures of counte-
nance, such as complete and prolonged lockdown.
Burioni’s declarations manifest several of the (possibly 
unconscious) manipulatory strategies listed above. For in-
stance, on March 22, in one of his regular interviews at the 
Infotainment program “Che tempo che fa” (anchored by Fa-
bio Fazio); Burioni states and prophesizes: “People believe 
in what they wish for. We all desire that a treatment arrives, 
which wipes away the disease, and we all would like to hear 
this good news. The good news will not arrive from the social 
media. It will arrive from the authorities”2.
This declaration reveals a series of misunderstandings re-
garding scientific authority, which critically compromise ra-
tional interventions in conditions of severe uncertainty, and 
may be exploited by the authority to paralyze dissent and 
deprive citizens of their civil rights3.
Let’s analyse the epistemological implications of this de-
claration. First of all the blame of wishful thinking (“Peo-
ple believe to what they wish”) misses, or better, reverses the 
point of the issue. Although it is true that we tend to believe 
what we desire and hope, it is also true that desires and ho-
pes ground any of our decisions. Desires express our system 
of preference, which is an essential component of rational 
choice. The essential point here however is, obviously, the ele-
ment of uncertainty intrinsic in the notion of desire: (Frank 
Ramsey sensibly stated in Truth and Probability: “No one 
feels strongly about things he takes for granted”) (Ramsey, 
1926). 
Hence, uncertainty about the efficacy of available tre-
atments (e.g. hydroxycholoroquine, convalescent plasma the-
rapy (CPT), heparin, or ivermectin), constituting an alterna-
tive to the usually most cherished but yet-to-be-discovered 
2 “Le persone credono a ciò che desiderano. Tutti desideriamo che 
arrivi un farmaco che scacci questa malattia e tutti vorrebbero 
avere questa buona notizia. La buona notizia non arriverà dai so-
cial media. Arriverà dalle autorità”.
3 Notwithstanding the borders closure, Italy’s brutal lockdown 
has been registered also far away from its territory: Durden Tyler 
(2020) Welcome to Orwellian Italy, ZeroHedge, 04/24/2020: https://
www.zerohedge.com/political/welcome-orwellian-italy-2020 (last 
visited 28th May 2020). 
one (i.e. vaccine) and/or to lucrative treatments (e.g Remdesi-
vir) by the majority of the expert, is used to disqualify them 
as non-existent”.
In order to do this, however, the expert must also dismiss 
the available evidence concerning such available treatments 
as “insufficient” or inadequate (see Section 3), and self-credit 
themselves as the only reliable source of information regar-
ding the available therapeutic options. 
The opacity and inaccessibility of scientific information 
for the lay audience does not allow them to evaluate the re-
liability of conflicting sources. In the absence of an arbiter, 
agents or groups of stakeholders possessing the majority of 
communication channels and strongholds, may have an easy 
game in getting their agenda through, by funding studies and 
organizing public relations campaigns that overwhelm the fi-
nancial and coordination capacities of independent voices.4 
The next step is outright censorship.
Censorship and selective reporting
The sentence “The good news will not arrive from the 
social media. It will arrive from the authorities” is however 
revealing of something more drastic than sheer paternalism 
and points directly to censorship and selective reporting by 
the accredited information sources. The COVID-19 emer-
gency has an abundance of examples to offer. Starting with 
the Italian Government that instituted a Task Force for the 
surveillance of fake news regarding COVID-195, with rela-
ted guidelines (Presidenza del Consiglio dei Ministri, Unità 
di monitoraggio COVID-19, 2020), up to the cases of tech 
giants, such as Google, Facebook, Twitter, Youtube and the 
like, that are adopting bans for non-aligned content and re-
directing information searches to governmental official sites. 
A particularly illicit behavior is Google application of their 
coronavirus misinformation policies to users’ personal files. 
Google Drive has started to take down users’ files in response 
to media complaints about them containing coronavirus mi-
sinformation. In an article reporting on the takedown (Par-
ker, 2020), The Washington Post’s Silicon Valley Correspon-
dent Elizabeth Dwoskin justifies such activity on the basis 
of the fact that after the coronavirus documentary Pande-
mic was censored on social media, some YouTube clips were 
telling users how to access “banned footage” from the do-
cumentary via Google Drive. Dwoskin also writes that The 
Washington Post reported 12 videos to YouTube, 61 Face-
4 This also generates methodological problems, given that aggrega-
tion studies, such as meta-analyses are assumed to be sampling 
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book posts and Instagram links to Facebook, and 24 videos 
to TikTok for featuring the Plandemic trailer. In response, 
YouTube removed five of the videos, Facebook removed nine 
of the posts, and TikTok said it removed most of the videos6.
Such increasingly overbearing practices by big tech com-
panies manifestly aiming to control and filter content (here, 
specifically, about COVID-19 related issues), to the point of 
removing private files of the platform users, not only violate 
fundamental freedoms of thought and speech, but also in-
fringe most basic privacy and information property rights. 
Most significantly, the definition of “misleading content” is 
obviously determined by the tech companies, with no clear 
details as to their rationale (see for instance: the Google Dri-
ve’s policies)7.
A step further in this escalation is a vaccine advocacy 
project, backed by a number of coalitions favoring vaccina-
tion, the National Foundation for Infectious Diseases, and 
funded by BIO, the world’s largest biotechnology lobbying 
group, gathering hundreds of pharmaceutical and biotech 
companies. The project is unprecedented in that it aims to 
“conscript an army of keyboard warriors trained to block, 
hide, and report” vaccine ‘misinformation’ (Wired, 2020). 
The project manager, Joe Smyser, is CEO of the “Public 
Good Project”, a public health nonprofit specialized in using 
social network analysis to implement large-scale behavioral 
change programs. The subtitle of the Wired article covering 
it is revealing: “Anti-vaccine messages on social media have 
tripled since the pandemic began. One public health group 
wants to teach pro-vaccine Americans to fight fire with fire”. 
Instead of transparently engaging with the public and hi-
ring experts to discuss the debated issues in the public arena, 
thousands of “everyday people who have some free time now 
and then to join the digital scrum” are enrolled in order to 
marginalize dissenting voices. The main goal of the project 
however is to go beyond persuasion and put pressure on po-
liticians so as to induce universal mandatory vaccination by 
“closing vaccine-exemption loopholes in state policies”. It 
seems indeed that no persuasion is as convincing as coercion, 
since research shows that rates of vaccination correlates most 
closely to States’ vaccine requirement policies (Omer et al. 
2018, Nyhan 2019). 
6 During her search for the elaboration of this article, one of the au-
thors saw the removal the content for at least three addresses: One, 
a Time article on the expulsion of WHO officials by the late Pre-
sident Nkurunziza in Burundi: https://time.com/5836654/burundi-
who-expulsion-election-coronavirus/; a second one, devoted to the 
pervasive bribery practices of the pharmaceutical industry with 
respect to physicians: http://www.italianosveglia.com/32000_medi-
ci_corrotti_da_case_farmaceutiche_il_nuovo_scandalo-b-107576.
html?fbclid=IwAR0E8RB-OcU-9NbhbYKif6zOnj9-rtS_3vQ_
lMABYTXVknWdjKtHLuGcQgw; and a third one, relating to 
material that had been stored on google drive: https://drive.google.
com/file/d/1pi6X3dPKjtrpmiVEdGT4vyCCw573IabG/view
7 https: / /support.google.com/docs/answer/148505?visit_
id=637256004092724506-3619940695&hl=en&rd=1 
Artificial inflation of scientific uncertainty
A step further on our scale regards the inflation of scien-
tific uncertainty for persuasive purposes. With “artificial in-
flation” of scientific uncertainty we denote all cases of strate-
gic interactions based on scientific evidence and knowledge, 
characterized by various sorts of asymmetries, where the de-
cision makers (the Principal in game-theoretic terms) or their 
associates (counselors) impose their cherished option, via: 1) 
using double standards of evidence so as to make unfavora-
ble options not enough supported by data for the decision 
at stake; 2) undermining the trustworthiness of sources of 
evidence which contrasts their interests; 3) undermining the 
reliability of non-aligned scientists (e.g. using ad hominem 
arguments and blame games). 
Double standards
The adoption of double standards for the evaluation of 
evidence depending on its content and implications seem to 
regard diverse therapeutic options already available in the 
COVID-19 case8: e.g. the off-label use of the malaria drug 
hydroxychloroquine (henceforth HCQ) in earlier stages of 
disease onset (Wang et al., 2020; Cortegiani et al., 2020; Ka-
poor & Kapoor, 2020; Gao et al., 2020; Tang et al., 2020); 
the compassionate use of the historically established conva-
lescent plasma transfusion (henceforth CPT) as rescue tre-
atment (Duan et al., 2020; da Silva, 2020; Zhao et al., 2020; 
Ye et al., 2020; Zeng et al., 2020; Bloch et al., 2020; Suthar et 
al., 2020); the use of low molecular weight heparin (EBPM) 
in patients in severe conditions to avoid worsening (Tang et 
al., 2020; Mycroft-West et al., 2020); and the wide-spectrum 
anthelmintic drug, ivermectin, usually used against parasites 
(i.e. scabies, onchocerciasis, strongyloidiasis, lymphatic fila-
riases; Caly et al., 2020; Wagstaff  et al 2011). We will focus 
here on the first two. 
Convalescent plasma therapy
Doctor De Donno, director of Pneumology at the Poma 
Hospital in Mantua, has started  with his collaborators an 
experimentation with CPT on about one hundred critically 
ill patients and found the immediate improvement and the 
subsequent, almost immediate, recovery of coronavirus pa-
tients. Throughout there were no deaths among the people 
treated; only patients who have improved to recovery or sta-
bilized. Nobody got worse. Furthermore, CPT responds fle-
xibly to the fast changing virus (Italian strains are different 
from Chinese or U.S. ones), in that patients are transfused 
with local convalescents’ plasma.
Scientists agree that although there is still no definitive 
data, this therapy, accompanied by other therapeutic tre-
atments can help reduce mortality (Rajendran et al., 2020). 
8 https://www.recoverytrial.net 
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Notwithstanding these promising results, and no availa-
ble alternatives, the Italian Higher Institute of Health (Istitu-
to Superiore di Sanità, ISS) has expressed so far cautionary 
advises on the topic (COVID Contents, 2020). ISS experts 
have stated that: “it is evident that polyclonal antibodies 
capable of neutralizing SARS-CoV-2 virus are developed 
in animal models as a result of natural or experimental in-
fection. Preliminary evidence is being consolidated that pla-
sma transfusion from convalescent subjects to SARS-CoV-2 
patients  can be therapeutically effective. The role of non-
neutralizing antibodies, which in the case of SARS in some 
cases have “stimulated”  viral replication, should be further 
investigated. However, it is still difficult to identify the linear 
or conformational target portions of the S protein on which to 
base the production of monoclonal antibodies for therapeutic 
purposes on a large scale” (COVID Contents, 2020). Hence 
against a long case series of successful outcome, ISS requests 
the acquisition of further evidence. This sort of objections 
seems to miss the point, since the pressing question during 
the emergency is not whether a given therapy can be develo-
ped on a large scale (which is of course desirable, but whose 
impossibility cannot be advanced as a point against its imple-
mentation), but to verify whether it works in the first place. 
It is however worth of notice that The ISS together with 
the Italian Medicines Agency (AIFA) are carrying out a na-
tional multicenter randomized controlled study in order to 
evaluate the efficacy and the role of plasma obtained from 
recovered COVID-19 patients, with a standardized protocol 
including severely ill patients. The aim is to obtain “solid” 
scientific evidence on the role of injecting antibodies from 
recovered patients in blocking the viral infections in diseased 
patients (AIFA, 2020). It seems however difficult to ethically 
understand random allocation of the currently only available 
therapy, although insecure, to severely ill patients (La Caze et 
Osimani 2020). Possibly, the study is a mixture of prospective 
studies and randomized controlled trials. Anyway, this would 
not change the issue in a relevant manner, and the press rele-
ase (AIFA, 2020) is too synthetic to understand the metho-
dological details. 
Hydroxichloroquine
The off-label use of HCQ followed analogous patterns. 
The treatment guidelines for COVID-19 issued by the NIH 
on 21 April recommended neither for nor against the use 
of HCQ. On 24 April, the Food and Drug Administra-
tion (FDA) issued a “drug safety communication” warning 
against the use of either hydroxychloroquine or chloroquine 
outside a hospital setting or clinical trial due to reports of 
“serious heart rhythm problems” (Carrie Wong, 2020). The 
updated guidelines do not give any recommendation, but 
only provide a critical report of the list of current studies on 
HCQ (NIH, 2020)9. Withdrawal from a negative judgment 
towards the drug might have been advised by the scandal 
related to deceitful publications on The Lancet and NEMJ, 
retracted for being grounded on fraudulent data (see rela-
ted section on scientific fraud). But, astonishingly, as of 15th 
June 2020, FDA has retracted the Emergency Use Authori-
zation for HCQ, mainly based on evidence on hospitalized 
patients, which is irrelevant for evaluating a preventive the-
rapy such as HCQ. “Early outpatient illness is very different 
than later hospitalized florid disease and the treatments dif-
fer. Evidence about use of hydroxychloroquine alone, or of 
hydroxychloroquine+azithromycin in inpatients, is irrelevant 
concerning efficacy of the pair in early high-risk outpatient 
disease” (Risch, 2020, our emphasis). Being cognizant about 
this, the FDA notification does not explicitly mention any 
of the studies made on inpatients, but only vaguely refers, 
neither mentioning the authors nor the publisher, to an 
RCT performed on healthy subjects, particularly exposed 
to the risk of contracting the virus. This is indeed the right 
target population for a preventive drug. However the study 
delivers a non-significant result due to ad hoc data analysis 
(see section on scientific fraud). One also discovers that the 
main author is a scientist working for Gilead, the company 
producing remdesivir (which is patented until 2037), a direct 
competitor of HCQ (no longer patented). 
Furthermore, neither the NIH guidelines, nor the retrac-
tion notification mention an epidemiological survey by Risch 
(2020), whose outcome is instead very positive for HCQ: 
“Five studies, including two controlled clinical trials, have 
demonstrated significant major outpatient treatment efficacy. 
Hydroxychloroquine+azithromycin has been used as stan-
dard-of-care in more than 300,000 older adults with multico-
morbidities, with estimated proportion diagnosed with car-
diac arrhythmias attributable to the medications 47/100,000 
users, of which estimated mortality is < 20%, 9/100,000 users, 
compared to the 10,000 Americans now dying each week”. 
The author concludes: “These medications need to be wi-
dely available and promoted immediately for physicians to 
prescribe”10.
The FDA decision to retract the EUA stays in stark con-
trast against obvious considerations, such as the unavailability 
of any alternative therapy for outpatients – Remdesivir has 
shown mild effectiveness in hospitalized inpatients, but no 
trials have been registered in outpatients – and the life-saving 
potential of the drug, considering the lethal course of the 
disease. The press release emphasize with understandable 
9 https://files.covid19treatmentguidelines.nih.gov/guidelines/co-
vid19treatmentguidelines.pdf, pp. 61-68.
10 Risch (2020) also notes: “An outpatient treatment that prevents 
hospitalization is desperately needed. Two candidate medications 
have been widely discussed: remdesivir, and hydroxychloroquine
+azithromycin. Hydroxychloroquine+azithromycin has been wi-
dely misrepresented in both clinical reports and public media, and 
outpatient trials results are not expected until September”.
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emphasis: “We remain committed to using every tool at our 
disposal in collaboration with innovators and researchers to 
provide sick patients timely access to appropriate new thera-
pies”. Excusatio non petita, accusatio manifesta11.
The basics of cost-benefit analysis would demand that 
when a lethal disease has yet not found any cure, then any 
emerging therapy, even supported by little evidence of effica-
cy (and safety), may be worth a try in order to possibly save 
lives. In our case, in the face of the virus-induced thrombo-
embolism, both HCQ, heparin, as well as plasma treatment 
are always better than leaving the patients to their destiny. In 
the face of sure death, anything goes and it is perfectly ratio-
nal. This kind of reasoning has been institutionalized in the 
so-called compassionate use (rescue treatment), but it seems 
not to cross the mind of many scientists, such as Remsidivir 
fan Anthony Fauci, Roberto Burioni, and the FDA officers, 
who keep on downplaying CPT or HCQ, while invoking 
the development of vaccines. It is indeed irrational to allow 
cherry-pick evidential standards in order to disqualify some 
treatments, when nothing else is still available. This is substan-
tially an abuse of evidence standards. Such abuse is also made 
possible because evidence standards are being often dogmati-
cally adhered to, without a full understanding of their rationa-
le and their true import (Osimani, 2020; Osimani et al., 2018; 
Landes et al., 2018; Osimani and Mignini, 2015).
The apex of such abuse has been reached in a NY hospi-
tal in which, according to the recorded witnesses of an emer-
gency nurse, economical incentives to intubate patients (the 
Hospital would receive $29,000 and additional supplies from 
the State), any alternative treatment with respect to the ho-
spital protocol, has been downplayed to the point of getting 
people worse and dye. A banned video12 records dialogues 
related to a case in which a 37 years old man entered the ho-
spital with respiratory distress, resulted negative to COVID 
tests and nevertheless was put into ventilation and died; com-
passionate use of alternative therapies proposed by nurses is 
persistently denied by the doctors (47’30” until the end).
Conspiracy theories
Another way to discredit non-aligned theories is to label 
them as “conspirationist”. For instance, regarding the pre-
viously mentioned google’s ban of the film “Pandemic”, the 
Washington Post’s Silicon Valley Correspondent Elizabeth 
Dwoskin frames users sharing files containing the Plandemic 
trailer with each other as: “people motivated to spread mi-
11 Luckily, HCQ is FDA approved for other conditions such as ma-
laria and the autoimmune disease Lupus erythematous; hence it 
can be prescribed off-label by the individual physician. This ho-
wever only underlines even more, if  necessary, the irrationality of 
the FDA decision. How can HCQ have a favorable risk-benefit 
profile for malaria and Lupus, and a negative one for a much more 
rapidly precipitating disease such as COVID-19?
12 https://banned.video/watch?id=5ee13c3cc7a607002f0c8187
sinformation about the virus – efforts that continue to thwart 
social media companies’ attempts at preventing hoaxes and 
conspiracy theories from spreading amid the greatest public 
health crisis in decades”.
Virus origin
Because of its implications regarding the matters we are 
discussing, the origin of the virus has been heatedly discus-
sed and the conspirationist label has been generally attached 
to those attributing its origin to lab experiments:
“Currently, there are speculations, rumors and conspira-
cy theories that SARS-CoV-2 is of laboratory origin. Some 
people have alleged that the human SARS-CoV-2 was lea-
ked directly from a laboratory in Wuhan where a bat CoV 
(RaTG13) was recently reported, which shared ≈96% homo-
logy with the SARS-CoV-2” (Liu et al., 2020). 
However, being RaTG13 (the Rhinolophus Affinis bat 
coronavirus living in a cave in Yunnan) considered putatively 
responsible for SARS-CoV 2002 by some, and having Sars-
Cov-2 a 96% genomic similarity with it, may genuinely sug-
gest that Sars-Cov-2 is the product of laboratory experiments 
on 2002 SARS-Cov.
Another hypothesis related to the laboratory origin of 
the virus emerged already in unsuspicious times in a 2015 
article appeared on Nature (Menachery et al., 2015)13, re-
porting about the experiment of a group of researchers, who 
had grafted the surface protein of SHC014 virus, taken from 
horseshoe bats in China, on the SARS virus taken from mice, 
thus creating a chimeric “supervirus” capable of affecting 
humans directly, without passing through an intermediate 
species. More specifically, the virus is able to affect human 
airway cells, and its surface protein structure is perfectly able 
to bind to a human receptor on the cells and to infect them. 
Such a characteristic seems to connect this chimera to the 
2020 coronavirus14.
However, in Andersen, et al. (2020) it is stated that the 
high-affinity binding of the SARS-CoV-2 spike protein to 
human ACE is most likely the result of natural selection on a 
human or human-like ACE2, and that this is strong evidence 
that SARS-CoV-2 is not the product of purposeful manipu-
13 An interesting reportage on this story also appeared in a TV dos-
sier dating back to 16th November 2015, hosted by RAI 3 (Italian 
national channel), edited by Maurizio Menicucci. 
14 Another piece of the story is that bat coronaviruses have been 
studied at the Wuhan Institute since 2013 (Butler, 2015). Fur-
ther support to the “covid-19 engineering theory”, is the fact that 
Xing-Yi Ge (Key Laboratory of Special Pathogens and Biosafe-
ty, Wuhan Institute of Virology, Chinese Academy of Sciences, 
Wuhan, China), one of the authors of the 2015 Nature article, had 
announced, already two years before, the isolation from bats of 
coronaviruses capable to bind to the key human receptor SHC014 
(Ge, Xing-Yi, et al., 2013). This means that the engineered coro-
navirus mentioned in the 2015 study was not the first one having 
such capacity (Butler, 2015). http://www.istitutoovidio.edu.it/at-
tachments/article/702/Coronavirus_Book.pdf
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lation: “the genetic data irrefutably show that SARS-CoV-2 
is not derived from any previously used virus backbone”. 
Furthermore, the Spike of the RaTG13 virus of the bat is 
very different from that of the SARS-CoV-2, and apparently 
not able to hook ACE2 (Andersen, et al., 2020; Zhang, et 
al., 2020), hence, according to Andersen and colleagues, this 
casts doubt on its engineered origin. 
In a March 2020 notification, the editors of Nature felt 
the need to express concern about the use of the aforemen-
tioned studies as a basis for theories on covid-19 engineering, 
pointing out both the lack of evidence to validate them and 
that scientists believe that an animal is the most likely source 
of the coronavirus (Butler, 2020). Yet, a series of experts 
such as Prof. Richard Ebright, molecular biologist (Board of 
Governors Professor of Chemistry and Chemical Biology at 
Rutgers University and Laboratory Director at the Waksman 
Institute of Microbiology, USA) and Prof Nicolai Petrovsky, 
contest the natural origin of the virus15. According to Prof 
Nicolai Petrovsky, endocrinologist and immunologist (Au-
stralian Academy of Science, Adelaide), the SARS-CoV-2 hi-
ghly infectiveness in humans, due to the spike protein ability 
to preferentially bind human ACE receptor with the highest 
binding affinity than any other known species, is definitely a 
“suspicious” element16 (Piplani et al., 2020).
Another element of suspicion regards the fact that the 
genomic sequence of RaTG13, allegedly discovered in 2013 
by Zheng-Li Shi, has been published only in January 202017. 
Is manipulation of viruses detectable?
Another controversy regards whether virus engineering 
or manipulation may or may not be detectable. The recei-
ved view is that since manipulations imply the insertion of 
long strands of DNA, engineering a virus leaves an evident 
mark, so it’s easily detectable. According to Massimo Galli, 
15 According to some, in order to incontrovertibly validate the natu-
ral origin of the virus one would not only need to obtain related 
viral sequences from animal sources, but also get to know how the 
spillover from animal to human exactly happened. These are all 
but trivial tasks. Some evidence in this direction is available but 
still fragmentary and therefore highly inconclusive. For instance, 
studies identified the pangolin as the probable intermediate in the 
bat-man transmission of the virus. (Lam et al., 2020) (Andersen et 
al., 2020) (Li et al., 2020) (Zhang and Holmes, 2020). https://www.
fisv.org/info-covid-19/435-origine-ed-evoluzione-di-sars-cov-2.html 
16 “SARS-CoV-2 is a highly adapted human pathogen” and “the 
data indicates that SARS-CoV-2 is uniquely adapted to infect hu-
mans” (Piplani, Singh, Winkler, Petrovsky, 2020). 
17 Zheng-Li Shi is an expert in bat coronavirus at the Wuhan Insti-
tute of Virology and working in the biosecurity-level laboratory 4 
(the highest one and the same used for smallpox and Ebola virus) 
and is also co-author of the RaTG13 2020 aforementioned work. 
It is really anomalous for a researcher to wait seven years before 
revealing such important discovery, and it is even more suspect 
that she decided to do so only when the covid-19 pandemic explo-
ded in Wuhan, as also Antoniou points out. https://www.youtube.
com/watch?v=F51jxe4B1uU
infectious disease expert and head of the Sacco hospital in 
Milan, and to Simon Wain-Hobson (Head of Molecular Re-
trovirology at the Pasteur Institute, Paris) an expert eye could 
immediately recognize something made in the lab18.
By contrast, other experts such as Prof Michael An-
toniou (Lecturer in Molecular Genetics at King’s College 
University, London), there are several ways to manipulate a 
viral genome without leaving any human trace. According 
to Antoniou, if  refined changes are made on some pairs of 
the genetic sequence of a bat coronavirus (i.e. the amino acid 
sequences of the Spike viral protein), then it is impossible to 
distinguish whether it is a mutation from natural selection 
or an intentional laboratory manipulation. This sort of fine-
tuned manipulations are possible thanks to the large amount 
of knowledge available on the viral proteins nature, so “you 
can precisely decide where going to manipulate. And if  you 
do it, you don’t leave a signature behind you”19.
Pathogenic properties of the virus
Another controversy related to the debate over the origin 
of the virus is represented by SARS-Cov-2 pluripathogenic 
properties (i.e. its ability to attack many organs at the same 
time). David Walt, Harvard Hughes Medical Institute Pro-
fessor, called this phenomenon highly unlikely to be found 
in nature, and Antoniou added that a scientist in the labora-
tory through mutagenesis saturation and selection methods 
can select these properties “and it would be much easier than 
waiting for them to happen naturally”20. More specifically, 
one can choose specifically which organ or cell to infect (e.g. 
lung cells, neurons, liver, muscles, etc.) until one finds “a va-
riant of the virus that can infect many types of these cells”21. 
Also, Robert Garry, virologist at Tulane University in New 
Orleans in Louisiana, didn’t find an explanation regarding 
the particular cleavage site that gives SARS-CoV-2 “a 100-
1,000 times greater chance than SARS-CoV of getting deep 
into the lungs”22. (Cyranoski, 2020) In a 2020 study the au-
thors argue that “the virus’s ability to infect and actively 
reproduce in the upper respiratory tract was something of 
a surprise, given that its close genetic relative, SARS-CoV, 
lacks that ability (Wölfel et al., 2020).
18 https://wargametechnology.weebly.com/blog-standard 
19 Indirect evidence of engineering activities regarding viruses comes 
also from the existence of so called “gain of function” research; 
a research program which seems to serve warfare purposes, sin-
ce its results are “dubious and dangerous”: Simon Wain-Hobson 
(Head of Molecular Retrovirology at the Pasteur Institute, Paris): 
https://www.youtube.com/watch?v=F51jxe4B1uU
20 The pioneer of the revolutionary use in the genetic and proteomic 
sequencing process of microwell arrays for single-molecule de-
tection and analysis https://wyss.harvard.edu/team/core-faculty/
david-walt
21 https://www.youtube.com/watch?v=F51jxe4B1uU
22 He said: “when I saw SARS-CoV-2 had that cleavage site, I did not 
sleep very well that night”. (Cyranoski, 2020)
37BarBara Osimani et al. Science as a weapon of mass distraction (the virus warfare)
Virus spread
Equally controversial and shady are the information 
about the origin of the virus spread. In a study conducted by 
the South China University (Xiao and Xiao, 2020), the bio-
logists Botao Xiao and Lei Xiao support the theory of the 
virus escape from a Wuhan laboratory, located near the city 
market, from which the epidemic seems to be arisen by direct 
transmission of the pathogen from bats to humans. Howe-
ver, as evidenced by witnesses, the bat would not be a food 
sold in the city and in particular in that market. Botao Xiao 
and Lei Xiao, argue that “the possible origins of the 2019-
nCoV coronavirus could have as a cause the infected animals 
kept in the laboratory by the Wuhan Disease Control Center 
(Whcdc), including 605 bats”23.
But what is more puzzling is the fact that, as a retrospec-
tive analysis reported, the virus emerged at the end of 2019 in 
France, (Spiteri et al., 2020) and since october 2019 in Italy, 
as reported by Dr. Manera, anesthesiologist at the Pope John 
XXIII Hospital in Bergamo24. With these findings, the sto-
ry of the Wuhan animal markets seems to falter and break 
down. Another French study, conducted by doctors at Jean-
Verdier Hospital in Bondy, Paris, found that a 42-year-old 
hospitalized on 27 December 2019 was ill with COVID-19. 
Moreover, the patient had not been in China in the previous 
months. (Deslandes et al., 2020).
The debate over the origin of the virus, its pathogenic 
properties and spread does not only have theoretical import, 
but has critical implications in geopolitical terms, since an 
engineered virus can be used not only for medical research 
purposes, but also as a bioweapon. In the latter eventuality, 
no one can exclude that it is spread in target areas for strate-
gic reasons. Although this may seem a gloomy sci-fi scenario 
to some, history is there to remind us that science has been 
put to the service of constructing nuclear weapons and vivi-
sect human people during WWII for instance, hence hastily 
dismissing the question over the virus origin, make-up and 
properties is culpably naïf, all the more since the controversy 
is all but settled. Establishing that the virus is natural or not, 
may also have considerable consequences as to the reliability 
of estimations regarding a “second wave” and their under-
pinnings. 
Blame game
As a next step to undermining unfavorable evidence, co-
mes the personal attacks to non-aligned scientists. 
The internationally renowned virologist, Giulio Tarro, 




25 L’allievo di Sabin, in La Repubblica, 13 aprile 2003 (consultato il 
31 maggio 2020).
object of this Blame Game. Tarro assumed an attitude of 
indictment towards high political and governmental offices, 
especially towards the Prime Minister Giuseppe Conte by 
pointing out that it’s “an idiocy” to wait for a vaccine which 
could never arrive (as for AIDS)26. Roberto Burioni criticized 
Tarro on this, by affirming the need and importance of a vac-
cine, while acknowledging the long time it takes to be found. 
The two scientists were the protagonists of a twitter spat in 
which Burioni stated: “If  Tarro is a Nobel virologist, I am 
Miss Italy”27. Burioni was then threatened with a lawsuit by 
Tarro, who defined him as “an allologist”28.
The Journalist Massimiliano Coccia attacked Tarro for 
inconsistencies that emerged in his CV, by reporting as false 
his statements on his person and professional experience29. 
Other protagonists of this story, such Alberto Zangrillo 
and De Donno received similar hostile treatments. Few days 
after announcing the successful outcomes of his CPT therapy 
at Mantua Hospital, Dr. De Donno received an inspection 
from the Hygiene Inspector Police (Nucleo Antisofisticazio-
ne e Salute). Dr. Alberto Zangrillo, received media cover on 
past controversies with the justice, soon after stating that the 
virus is clinically dead, based on evidence that Intensive Care 
Units at his hospital had not been receiving COVID-19 pa-
tients for weeks30.
26 Claudio Franceschini, Giulio Tarro “Galera per i pro-vax”/ Video, 
“Conte vuole il vaccino? È un’idiozia”, su ilsussidiario.net, 22 aprile 







29 Massimiliano Coccia, Chi è davvero Giulio Tarro, il virologo anti-
Burioni e De Luca. Tra titoli inventati e bufale, su  l’Espresso, 24 
aprile 2020 (consultato il 31 maggio 2020). The virologist was also 
attacked by colleagues for his opinions about COVID-19, more 
specifically for making a statement as based on a “spurious corre-
lation” in claiming that: “36% of coronavirus is activated precisely 
by flu vaccinations”, a percentage that seems to have been taken 
from what the Councilor of the Lombardia Region, Giulio Gal-
lera, said previously, that is: “36% of cases affected the over-75s” 
in his region, a segment of the population that most likely had 
made the flu vaccine (see: Juanne Pili, Coronavirus. Le tre strane 
dichiarazioni di Giulio Tarro sul COVID-19 e le vaccinazioni antin-
fluenzali, su Open, 23 aprile 2020; and Claudio Franceschini, Giu-
lio Tarro “Galera per i pro-vax”/ Video, “Conte vuole il vaccino? E’ 
un’idiozia”, su ilsussidiario.net, 22 aprile 2020. URL consultato il 
31 maggio 2020). However, Tarro’s theory is indirectly supported 
by the January 2020 US Pentagon study (Wolff, 2020), which re-
ports that “the odds of coronavirus in vaccinated individuals were 
significantly higher when compared to unvaccinated individuals 
with an odd of 1.36. The vaccinated were 36% more likely to get 
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Scientific propaganda
This is the other side of the censorship coin. Whereas 
scientists non-aligned with the narrative cherished by the 
pharmaceutical industry and other lobbying stakeholders are 
marginalized, silenced and blame-gamed, those who work 
for such groups are interviewed ubiquitously in the main-
stream media, pontificating about possible second waves and 
hypothetical, indispensible, vaccines. 
The Medical Association AMPAS issued a Public Notice 
on the topic, and other related issues (AMPAS, 2020). The 
Notice denounces the climate of propaganda of the accre-
dited media broadcasting 24/7 COVID-19 information, by 
repeatedly inviting the very same experts (known to be affi-
liated and generously paid by interested parties), without any 
adversarial voice. 
The AMPAS president, Dr. Luca Speciani laments a 
violent information strategy and climate of opinion crime31. 
Following a series of considerations the Notice asks for the 
immediate establishment of a balanced participation of all 
scientific voices and opinions in TV shows and the like (a 
sort of scientific “par condicio”), with the obligation for any 
scientific expert appearing in the media to declare their con-
flicts of interest, the prohibition of content removal from in-
ternet platforms, unless for severe violations of the law, and 
the prohibition to disbar doctors from Medical Associations, 
only based on their opinions. The fact that these requests 
need to be advanced is a clear sign of the point to which free-
dom of speech and opinion has been repressed during the 
COVID-19 emergency. 
Scientific fraud
One of the most striking news in the middle of the CO-
VID-19 “Infodemia” was Lancet retraction (Lancet, 2020) 
on June 4th 2020 of the study: “Hydroxychloroquine or ch-
loroquine with or without a macrolide for treatment of CO-
VID-19: a multinational registry analysis” (Mehra et al., 
2020a), published just few days before on May 22, 2020. 
The retraction came after a heated debate on the effica-
cy and safety of HCQ, used by Dr. Didier Raoult (Director 
of the Clinical Microbiology Laboratory for the University 
Hospitals at Marseilles) and colleagues in order to treat early 
stage COVID-19 patients at their hospital, resulting in a de-
ath rate of 0.009% out of 4000 otherwise successfully treated 
loro-vanno-zittiti-e-delegittimati/
31 “They never called on us, because there is a plot and they must 
keep on maintaining panic until vaccines arrive. But people must 
know why always the same people talk [in the accredited media], 
and that these people received vast amounts of money from phar-
maceutical companies. A simple declaration of conflicts of inte-
rest would do, as it is done at congresses and in scientific publi-
cations. It would help people understand that not everybody is 
speaking in the name of Science, even if  they say so”: https://www.
oltre.tv/dottor-speciani-mantenere-panico-arrivo-vaccino/.
patient. The Lancet study, ascertaining lack of efficacy and 
suggesting safety issues for HCQ, was in fact based on tain-
ted data. These were claimed to come from a large dataset, 
which later revealed to be non-existent, owned by Surgisphe-
re, a company founded by one of the study authors, Sapan 
Desai32.
The Lancet study was a rush job, holds Paul Craig Ro-
bert (Institute of Political Economy), since “it was essential 
for Big Pharma to prevent the spread of the HCQ treatment, 
and awareness of its safety and effectiveness.  The study’s 
authors completed the data collection around the middle of 
April and the study was published on May 22. It was used to 
close down the WHO’s clinical trial of hydroxychloroquine 
in coronavirus patients citing safety concerns. Most likely, the 
trial was aborted in order to prevent an official agency from 
finding out that HCQ worked […]. The intent is to bury HCQ 
as a low cost effective treatment and to put in its place a high 
cost alternative whether effective or not, and to supplement 
this enhancement of profits with mass vaccination which 
might do us more harm than the virus itself”33. 
Noticeably, The Lancet was not the only journal falling 
in the trap, since also another high league journal, the New 
England Journal of Medicine, published a peer-reviewed study 
based on “the same” Surgisphere data submitted by the same 
authors (Mehra et al., 2020b). This study, supposed to inclu-
de “data” from COVID-19 patients from apparently 169 ho-
spitals in 11 countries in Asia, Europe and North America, 
was retracted by NEJM on the same days.
Less in the spotlight, but a real telltale sign of how the 
scientific publication system has been captured by indust-
ry interests, is the case of yet another study published by 
NEJM. This is a study by Boulware and colleagues (Boulwa-
re et al., 2020), claiming no significant association between 
HCQ and COVID-19 recovery endpoints. Under the scru-
tiny of “Collectiv Citoyen France Soir” (Le Collectiv Ci-
toyen France Soir, 2020), such lack of association is revea-
led to be the result of ad hoc subgroup analyses (so called 
“HARKing”: Kerr, 1998). When taking the entire sample, 
the association magically reemerges34. The mystery of such 
32 Only few days after being issued, Guardian Australia  revealed 
conspicuous errors in the Australian data  included in the study: 
“The study said researchers gained access to data through Sur-
gisphere from five hospitals, recording 600 Australian Covid-19 
patients and 73 Australian deaths as of 21 April. But data from 
Johns Hopkins University shows only 67 deaths from Covid-19 
had been recorded in Australia by 21 April. The number did not 
rise to 73 until 23 April”. Five hospitals in Melbourne and two 
in Sydney, essential for obtaining the Australian patient numbers 
claimed to be available in Surgisphere database, denied any role in 
such a database, and said they had never heard of Surgisphere. 
33 https://www.paulcraigroberts.org/2020/05/28/the-campaign-
against-hcq-part-ii/. 
34 “Si on fait l’analyse comme les auteurs l’on fait, sur 1 jour à 4 jours 
indépendamment on trouve des différences non significatives. Cela 
veut dire que l’écart de mesure entre les deux chiffres ne peut pas 
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a “counterintuitive” choice of analysis is solved when one 
searches for authors’ affiliations and finds out that Boulware 
actively collaborates with Gilead, the producer of remdesivir, 
HCQ direct competitor35.
The sample of other contemporary studies analyzing the 
therapeutic effects of HCQ with respect to COVID-19 also 
show inefficacy or possible cardiac issues with HCQ. Among 
these we find e.g. a retrospective study in France, a US study 
on veterans, and an aborted Brazilian trial (see NIH 2020). 
Here the observation of negative results may be effortlessly 
be explained by the illogic (or strategic?) inclusion crite-
ria. Patients mainly belong to late stages of the disease (or 
to multimorbidity groups), which is a non-sense given that 
HCQ is thought of as a prophylactic with exclusive preven-
tive virtues, hence plainly powerless against damages caused 
by the virus.
The boldness of such moves is even more evident if  one 
considers that HCQ has a long history of safe use for mala-
ria, and that evidence for its efficacy as a prophylactic measu-
re against COVD-19 can no longer be considered anecdotal 
(Nina and Dash 2020). Indeed Raoult and colleagues had 
already published a paper in 2007 reviewing the safety profile 
of the drug for repurposing it against infections from SARS-
COV with positive results, and the US National Institutes 
of Health published studies in its journal “Virology” touting 
chloroquine as “a potent inhibitor of SARS coronavirus in-
fection” as far back as 2005 (Vincent et al., 2005)36.
However, as Andrew Gelman (Gelman, 2016) noticed 
regarding a similar retraction in 2016 (for the controversial 
PACE study), reputation is a two-way street: “The Lancet 
editor is using his journal’s reputation to defend the con-
troversial study. But, as the study becomes more and more 
disparaged, the sharing of reputation goes the other way”. 
Indeed as never before, the COVID-19 emergency is showing 
to the world how naively oversimplified is the view of science 
être considéré comme pouvant entraîner une conclusion comme 
quoi le traitement fonctionne mieux que le placebo. Les bases sta-
tistiques apparaissent fiables même si les échantillons sont un peu 
petits et donc cela rend les tests statistiques plus délicats. Mais 
avec la science statistique allons plus loin. Quand on regroupe 
les échantillons en personne étant exposées 1 à 2 jours ou 1 à 3 
jours donc avec des échantillons plus grands et donc plus fiables, 
là les tests deviennent significatifs. Ainsi la conclusion de l’étude 
Boulware est erronée. Ce qui plaiderait en faveur de l’hydroychlo-
roquine et changerait les conclusions de cette etude”. 
35 Paradoxically (?), in their editorial introduction to Bouleware’s 
and colleagues’ paper, NEMJ state: “So, what are we to do with 
the results of this trial? The advocacy and widespread use of 
hydroxychloroquine seem to reflect a reasonable fear of SARS-
CoV-2 infection. However, it would appear that to some extent the 
media and social forces – rather than medical evidence – are dri-
ving clinical decisions and the global Covid-19 research agenda”. 
(Cohen, 2020, p. 2).
36 Yet “coronavirus czar Anthony Fauci throws shade at the drug 
whenever he gets a chance” (Buyniski, 2020). 
as a microcosm of diligent pursuers of truth (García, 2019; 
Bucci, 2015; McGarity and Wagner, 2008).
Authoritarianism 
The above mentioned AMPAS press release (AMPAS 
2020) expresses concern about the exercise of certain fun-
damental rights of citizens. In particular, it emphasizes the 
lesion of constitutional rights such as freedom of movement, 
the right to study, the possibility of work, and the possibility 
of access to care for all non-coronavirus patients; and sero-
logical tests for all. In addition, several possible consequen-
ces of Italian political choices are analyzed from a medical 
perspective: the impediment of sporting activity affects both 
the constitutional rights and the psychophysical health of 
citizens. Isolation is likely to have not only particularly psy-
chological distressful implications, but also serious economic 
consequences, which will have an impact on public health in 
turn. 
In Italy the Government apparently delegated all his 
emergency strategy to a series of task forces, whose first step 
was to ask for legal immunity regarding their recommenda-
tions. In the end, the task forces acted as a screen for the go-
vernment to enact unwelcome and illegitimate policies, such 
as a draconian lockdown measures, and their enforcement 
manu militari, without taking direct responsibility for them.
Suppression of scientific investigation: 
“scientific lockdown”
The Italian Government issued a ministerial newsletter 
on 8th of April (Ministero della Salute, 2020), where it was 
suggested to avoid autopsies, while criteria in case a facility 
would decide to actually practice an autopsy. The consequen-
ce of these indications was a drastic reduction in the num-
ber of autopsies. It is utmost suspicious that in the face of 
total ignorance about the pathophysiology of the COVID 
disease, the responsible authorities have discouraged such 
an important means of investigation as autopsies (Aguiar et 
al., 2020; Pomara et al., 2020; Salerno et al., 2020). “Autopsy 
remains the gold standard to determine why and how death 
happens. Defining the pathophysiology of death is not only 
limited to forensic considerations; it may also provide useful 
clinical and epidemiologic insights. Selective approaches to 
postmortem diagnosis, such as limited postmortem sampling 
over full autopsy, can also be useful in the control of disease 
outbreaks and provide valuable knowledge for managing ap-
propriate control measures” (Pomara et al., 2020). It is also 
no alibi that autopsies have been discouraged to safeguard 
the health of health professionals for two reasons: 1) the 
virus becomes innocuous once the host is dead; 2) forensic 
doctors performing autopsies wear special protective suits, 
included masks and gloves all the time. It is also no excuse 
that the emergency hit without notice and did not allow us 
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to be prepared, since the recommendation to avoid autopsies 
was reaffirmed on a later newsletter on 2nd May. 
Indeed, it is exactly thanks to some “dissident” doctors, 
such as Giampaolo Palma and Stefano Manera, that the le-
thal outcome of the virus was finally correctly diagnosed: 
death from COVID-19 was not due to pneumonia but to 
thromboembolism. If  made in due time, this diagnosis would 
have saved most lives hit by the epidemics. Indeed ventilators, 
which were used in order to counteract respiratory distress 
have caused more harm than good in such conditions. 
Delay/obstruction/ suppression of clinical practices
The application of double standards to non-lucrative 
therapies such as HCQ and CPT is obviously delaying their 
implementation. This grossly violates the Doctor’s prescrip-
tion authority: that is the Doctors’ freedom to choose the 
best therapy for their patients, based on the individual risk-
benefit profile and the citizen’s health freedom (Osimani, 
2007, 2010, 2013). Such interference has sometimes become 
an outright suppression of such freedom, for instance with 
Governor’s Andrew Cuomo outright ban of HCQ in the Sta-
te of New York. 
Another chapter of this story has been the delay and re-
nitence in authorizing access to serological tests. Such tests 
are not expensive and identify distinct types of antibodies 
as a function of (IgM), or (so called “memory antibodies” 
IgG). This information, together with other clinical and epi-
demiological data may help distinguish immunized vs. non 
immunized people with a certain accuracy. Hence, they allow 
more rational containment measures, by permitting that tho-
se that have already been infected but are now healed, may 
go back to work and perform their usual activities without 
endangering oneself  or the other. This approach would have 
saved much psychological distress, not to mention the enor-
mous difference it would have had on economics and society. 
In the same Public Notice mentioned above, the AMPAS 
wonders why the Italian Government, and Health Institu-
tions more generally, have been so hostile towards serological 
tests to the point of banning them until reliable tests are ap-
proved. This is totally irrational in a situation of emergency, 
where even a coarse discrimination between infected, non-
infected and recovered would be enormously helpful. 
Exploitation of death tolls to silence opposition
The pandemic tragedy has not hindered profiteering of 
death tolls for silencing governmental oppositions, or vice 
versa to retaliate and attack specific governments. In Italy, 
as soon as the judiciary started criminal investigations on 
the Regions most hit by the COVID-19, which are ruled by 
opposition parties, the parliamentary opposition against the 
Government comprehensibly slowed down.
One member of the Majority Party (Partito Democratico, 
PD) had the idea to counterfactually estimate the number of 
casualties, were the opposition at the government: according 
to his exact computations, cemeteries would have not been 
enough. Probably averse to bookkeeping, another member 
of the same party put it more metaphorically, speaking of an 
anticultural legacy that cost “thousands of deaths”37. 
This kind of considerations is echoed in the Italian and 
international arena, where leaders non aligning with the me-
dicalization agenda are being blamed for mismanaging the 
COVID-19 emergency. These are criticized for downplaying 
the risk and “science denialism” (Haltiwanger, 2020; Pitzian-
ti, 2020). A curious allegation, since these leaders are the 
same that first asked to contain the epidemics by closing bor-
ders; a proposal that WHO rejected for being discriminatory 
against the Chinese people. Furthermore, these accusations 
keep on hiding the fact that although e.g. UK, US; Russia, 
Brazil and India rank among the highest for number of cases, 
the same does not hold for deaths or serious and critical pa-
tients. Hence this means that they might not be good at stop-
ping the virus from being spread around, but at least they 
seem able to prevent it to harm. 
Malevolent social planning
The convergence of a series of mistakes such as the una-
vailability of face-masks when they were most needed, and 
their later imposition in the open air, where they are harmful; 
the hesitancy to close national borders when they would have 
dammed the virus penetration from the most infected areas, 
and the drastic containment measures inflicted two weeks la-
ter on citizens, by prohibiting anyone to move from one mu-
nicipality to the other (unless for basic certified needs); the 
untimeliness of lockdown measures and their punitive style, 
all jointly contributed to the rising suspicion that all these 
measures were part of a plot designed by a “malevolent” so-
cial planner, i.e. politicians driven by personal interests, to 
the expense of those of the community, whose welfare, safe-
ty and security, they are supposed to strive for. Undeniably, 
the policymaker has been perceived as someone abusing their 
position, in order to curb resistance, and bend the population 
will against several unpopular policies in sight.
The suspicion of malevolence is somewhat reinforced by 
the fact that pre-existing information, which seemed to pre-
dict the COVID-19 outbreak, has been long in the hand of 
the scientific community and of interested authorities (see: 
Cheng et al., 2007; Antonelli et al., 2017). After Ebola and 
Sars, epidemiologists and scientists around the world have 
repeatedly warned governments of the likely arrival of a new 
virus. Among them, Vincent Racaniello, a Higgins professor 
in the Department of Microbiology and Immunology at Co-
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Maria Van Kerkhove (WHO technical guide on COVID-19). 
The question then naturally arises whether the COVID-19 
outbreak was somehow already foreseen (or predictable) and 
therefore whether prevention measures could have been ta-
ken in due anticipation by the relevant Authorities at natio-
nal and supranational level, so as to avoid (economically dre-
adful) lockdown measures and reduce the number of deaths. 
Such forecasts were believable and available, so their neglect 
is perplexing and casts doubt on the bona fide of those re-
sponsible for taking action on their basis.
Furthermore, some of the lockdown measures have been 
not only very harsh, but also seem utterly counterproductive: 
the prohibition to practice sport activities in the open air, or 
to have a solitary bath in the sea, to walk in the wood or in 
the public gardens, and the related physical and psychologi-
cal distress, are all measures that weaken the immune system 
and therefore make people more susceptible to the virus, 
rather than contain the epidemics. Also absolutely incom-
prehensible from a medical point of view is the recommenda-
tion not to seek for professional health assistance at the ap-
pearance of suspicious signs of the infection, and instead to 
await while treating early symptoms with antipyretics: fever 
is universally known to be a powerful natural antiviral me-
chanism, therefore suppressing it is the opposite of what one 
would do in the case of a viral infection. Moreover, self-care 
becomes rapidly useless with COVID-19, since the clinical 
picture of this disease may quickly deteriorate in particularly 
susceptible subjects. 
This is all the more striking since Governments have ba-
sed these and other recommendations and policies on the 
suggestions of specialized agencies (such as the World He-
alth Organization), and task forces of experts. Among these, 
the recommendation provided by WHO to refer COVID-19 
patients into nursing homes, that is into communities com-
prising the most fragile and virus-susceptible people. The 
hecatomb of deaths in Lombardy is mainly due to this nefa-
rious protocol. This is paradoxical also in view of the harsh 
isolation measures imposed on the entire population of he-
althy and less susceptible people.
At this point, it would be thus culpably naïf  to think that 
these agencies are neutral transmitters of scientific knowled-
ge, untouched by personal interests (whether financial or in 
terms of career advancement and prestige), or by the manda-
te of lobbyist groups. 
One informative sign that they are not exactly there to 
help people solve their problems, is the fact that they have 
been asking, and obtained, to be exempted from any legal 
liability regarding the consequences of the interventions that 
would result from their counseling. This happened for the 15 
Task Forces comprising more than 400 experts established 
by the Italian Government, and also for the legal indemnity 
on vaccines granted by FDA to pharmaceutical industry and 
also to Bill Gates (Public Readiness and Emergency Prepa-
redness Act: PREPP; PHE 2020; see also Sullivan, 2018 for 
a Court precedent)38.
Supranational agencies, such as WHO, are also not im-
pervious to extrinsic agendas, since their funding is overwhel-
mingly of private origin (mainly pharmaceutical companies). 
Furthermore, geopolitical games may interfere with the 
Agency’s inherent mission even through public funding only, 
since the political weight of each country in determining the 
Ageny’s policy may well be proportionate to the generosity 
of its contribution39.
The suspicion that the several “mistakes” made by WHO 
and various governments with astonishing coordination are 
means to an end of a cleverly engineered plot may well be 
tagged as a conspiracy theory. But all the cues emerged so far, 
and the convergence of synergic motives by several agencies 
at play, make for a smoking gun. 
Further confirmations in this respect are mounting up at 
a remarkable rate: Bill Gates, a private billionaire with no 
degree in Medicine, was received by many Heads of State and 
concluded multimillionaire agreements for vaccines commis-
sions, even before they are developed, and with dim prospects 
about how and if  they will ever come out. Given the highly 
38 Children’S Health Defense sets a connection between Gates’ re-
quest of legal immunity and scientists’ attempts to develop a virus 
for the first Sars-Cov: “Scientists first attempted to develop coro-
navirus vaccines after China’s 2002 SARS-CoV outbreak. Teams 
of US & foreign scientists vaccinated animals with the four most 
promising vaccines. At first, the experiment seemed successful 
as all the animals developed a robust antibody response to co-
ronavirus. However, when the scientists exposed the vaccinated 
animals to the wild virus, the results were horrifying. Vaccinated 
animals suffered hyper-immune responses including inflammation 
throughout their bodies, especially in their lungs. Researchers had 
seen this same “enhanced immune response” during human te-
sting of the  failed RSV vaccine tests  in the 1960s. Two children 
died. […] Fauci has made the reckless choice to fast track vacci-
nes, partially funded by Gates, without critical animal studies be-
fore moving into human clinical trials that could provide early 
warning of runaway immune response. Gates (in the video) is so 
worried about the danger of adverse events that he says vaccines 
shouldn’t be distributed until governments  agree to indemni-
ty against lawsuits”. Indeed, indemnity has been obtained throu-
gh Federal regulations giving coronavirus vaccine producers full 
immunity from liability.
39 A fragment from Sharav’s dossier on Children’s Health defence 
mentions the “(a) the collusion of public health officials to deceive 
the public by concealing scientific evidence that confirms empi-
rical evidence of serious harm linked to vaccines – in particular 
polyvalent vaccines; (b) the “willful blindness” by the medical 
community as it uncritically fell in line with a government dictated 
vaccination policy driven by corporate business interests. Public 
health officials and the medical profession have abrogated their 
professional, public, and human responsibility, by failing to hone-
stly examine the iatrogenic harm caused by expansive, indiscrimi-
nate, and increasingly aggressive vaccination policies. On a human 
level, the documented evidence shows a callous disregard for the 
plight of thousands of children who suffer irreversible harm, as if  
they were unavoidable “collateral damage” (Sharav, 2020).
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contentious issue, the signature of such agreements should 
at least have been preceded by a parliamentary discussion, 
when not a public one. Failing to arrange a transparent di-
scussion and to involve society further jeopardizes the alrea-
dy crumbly trust in the scientific enterprise, and especially in 
the information provided by interested knowledge producers. 
Science policy becomes politicization of science (Tallacchini, 
2019). Whereas the former sets up a dynamic and transpa-
rent interaction between science and democracy, based on 
the authoritativeness of the producers of scientific knowled-
ge, and the authority conferred on people’s representatives by 
established democratic processes and institutions, the latter 
adopts an authoritarian stand and abuses science, by using 
it directly as a power needing no justification, qua science. 
Information wars
The strategic importance of contemporary science as a 
weapon in geopolitical terms is evidenced by heinous epi-
sodes and diplomatic incidents that occurred during the 
COVID-19 emergency. Apart from the notorious dispute 
between the President of the United States Donald Trump 
and the World Health Organization, as well as China, regar-
ding the timely disclosure of material evidence for control-
ling the spread of the epidemics, and the timeliness of sug-
gested countenance measures with respect to their outcomes 
(Trump, 2020), other affairs in this chapter are worth of note.
DOE, NIH and DODE investigation on Ivy League 
Universities
The most prominent, although gone on the sly in the 
mainstream media is the U.S. Department of Education 
(DOE) decision to open an investigation on Yale and Har-
vard universities for failing to disclose contracts, gifts and 
donations from foreign donors, such as China, Saudi Ara-
bia, Qatar, Russia, United Arab States, Huawei Technologies 
and ZTE. The latter two were included on a U.S. sanctions 
blacklist the previous year on grounds of being national se-
curity threats (FCC, 2019). A Senate report as of February 
2019, describes the influence of China on the U.S. academic 
system as “effectively a blackhole” (U.S. Senate, 2019), and a 
letter from DOE general counsel Reed D. Rubinstein to Sen. 
Rob Portman, the chairman of the committee that authored 
the Senate report, China’s Communist Party “invests strate-
gically” in the U.S. education system and such investments 
come with constraints that can interfere with academic free-
dom (U.S. DOE, 2019). The letter also reports investigations 
from the U.S. DOE and congressional findings revealing that 
the six investigated universities failed to disclose $1.3 billion 
excess from foreign sources; one U.S. university “received re-
search funding from a Chinese multinational conglomerate 
to develop new algorithms and advance biometric security 
techniques for crowd surveillance capabilities”; more gene-
rally, most donations and funding were linked to dissemina-
tion of propaganda, “soft power” information activities, or 
stealing sensitive and proprietary research and development 
data, as well as other intellectual property. These findings 
were agreed in many respects with analogous UK reports 
on similar matters (UK Parliament FA, 2019) and other UK 
Institutes reports (Parton, 2019; UK Conservative Party Hu-
man Rights Commission, 2019).
Following such investigations, both Yale and Harvard 
are accused of soliciting funds from foreign governments, 
companies and individuals who are hostile to the US and 
looking to steal classified research (O’Keefe, 2020). The inve-
stigation is being fostered by a bipartisan group in Congress 
and conducted by a coalition of federal law enforcement, the 
National Institutes of Health, and the Departments of De-
fense and Energy (O’Keefe, 2020). 
This Notice of investigation came after the arrest of Char-
les Lieber, former Chair of Harvard University’s Chemistry 
and Chemical Biology Department, who was also involved 
in China’s strategic research programs, such as the Thousand 
Talents Program” mentioned in the DOE notice of investiga-
tion40. The Thousand Talents Program was started in 2008 
to invite excelling Chinese scientists working abroad back to 
China, and then became, according to the above mentioned 
legal documents, a recruitment plan seeking to entice foreign 
and Chinese minds working in overseas institutions to bring 
their knowledge and experience to China, often rewarding 
them for stealing proprietary information (U.S. DOE, 2019). 
The NIH initially became aware of ethical breaches re-
garding classified research or intellectual property rights, be-
cause identical grants were submitted to several agencies, and 
most strikingly, confidential grant applications from other 
researchers were shared with collaborators in China. Beyond 
the case of Lieber that reached visibility in the media, up 
to 180 other scientists were investigated or “debarred”, and 
letters sent to 60 institutions (Mervis, 2019). The most pro-
minent case is NIH resolution to defund a longstanding re-
search project, “Understanding the Risk of Bat Coronavirus 
Emergence”, led by EcoHealth Alliance, Inc, a non-profit 
research agency based in NY and Shi Zhengli41, a virologi-
st based at the Wuhan Institute of Virology (WIV). Beyond 
the production of several scientific publications, the project 
also led to the disclosure of several genetic sequences of bat 
coronaviruses, which have been used in the development of 
40 Beginning 2011 Lieber became a “strategic scientist” at Wuhan 
University of Technology (WUT). The notice of DOE to the Presi-




41 The resolution took place on 24th April 2020 and the termination 
letter is available here: https://nlcampaigns.org/NIH_termina-
tion_letter_to_Daszak_4_24_20.pdf
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Remdesivir (a potential pharmaceutical treatment for CO-
VID-19)42.
Pierre Nkurunziza’s unexpected death
A most miserable case of “information war” is also re-
presented by the sudden death of the President of Burundi, 
Pierre Nkurunziza on 8th June 2020. The sad news has been 
given with some skepticism regarding the apparent cause of 
his death e.g. by the BBC News: “Burundi President Pierre 
Nkurunziza dies of ‘cardiac arrest’ at 55”43. Indeed, Nkurun-
ziza had expelled six WHO officials from his country just few 
days before, with a directive dated 12th May, which should 
be executed on May 15th. The Health Minister motivated 
this decision on grounds of unacceptable interference by 
the WHO in the management of the emergency44. The unex-
pected death of Nkurunziza casts a gloomy shadow on the 
entire affair, which is indeed emphasized by the disappearan-
ce of the news concerning his expulsion of WHO’s official 
from the Time website45. 
Science tyranny: the therapeutic state
In view of the irrationality of some lockdown and con-
tainment measures, the propaganda machine put into place, 
and the censorship of any non-aligned voice, the COVID-19 
emergency may reasonably perceived as a troy horse for the 
enactment of agendas cherished by some industry lobbies, 
and an excuse for top-down shaping a new society, without a 
genuine democratic involvement.
This is especially the case for contentious topics such as 
mandatory vaccination and “Immunity Passports”. With the 
imposition of vaccination, through “nudging” (such as condi-
tioning civil freedoms to immunity), or obligation, we come 
to the heart of the problem. 
42 In a warning email to EcoHealth that preceded the defunding 
resolution, written by the NIH Deputy Director for Extramural 
Research, Michael Lauer, it is stated: “The scientific communi-
ty believes that the coronavirus causing COVID-19 jumped from 
bats to humans likely in Wuhan where the COVID-19 pandemic 
began. There are now allegations that the current crisis was pre-
cipitated by the release from Wuhan Institute of Virology of the 
coronavirus responsible for COVID-19. Given these concerns, we 
are pursuing suspension of Wuhan Institute of Virology from par-
ticipation in federal programs”: https://www.sciencemag.org/sites/
default/files/Lauer.Daszak.NIH%20grant%20killed.partial%20
email%20transcripts.April%202020.pdf
43 The reader familiar with journalism’s rhetoric will have noted that 







Vaccination is an extremely problematic health techno-
logy46. First of all, the debate is polarized and confused by 
coalescing seasonal vaccines with other kinds of vaccines, 
e.g. those developed to fight measles or polio; whose risk-be-
nefit profile are fundamentally different, in that they prevent 
irreversible and severely disabling diseases. Such confusion 
extends to the concept of herd immunity. Whereas herd im-
munity has been instrumental for the permanent eradication 
of infectious diseases such as smallpox, typhoid or chicken-
pox, etc., it makes very little sense to use it as a lever to intro-
duce mandatory vaccination for seasonal flu, which cannot 
be eradicated, since it comes again every year with different 
viral strains. 
However, seasonal vaccines have become the attractors 
of huge financial interests, exactly because if  herd immunity 
is set to be the target, then it is also implied that vaccines 
should be administered to as large as possible sectors of the 
population. In turn, this means a much bigger market than 
therapeutics, whose market share is determined by their in-
dication.
However, seasonal vaccines are known to be a sort of bet 
on the target virus, since they are developed by estimating its 
profile on the basis of its precursors; viral interference is also 
an issue, since it is not uncommon that subjects vaccinated 
against a specific strain develop a, possibly lethal, hyperim-
mune reaction when exposed to another viral strain. Final-
ly, vaccines, as any other health technology, have inevitable 
collateral effects. But since they are administered to healthy 
people, safety requirements should be much stricter than for 
therapeutic treatments aimed to cure sick people. 
Against this background as well as the constitutional 
rights of health freedom and doctor’s prescription authori-
ty (not to mention the Oviedo Convention: Council of Eu-
rope, 1997), the increasing interference of the legislator on 
therapeutic choices, such as the decision to vaccinate oneself  
against seasonal flu, represents a worrying approach to the 
relationship between science and the law, which contradicts 
the intrinsic mission of both institutions (Tallacchini, 2018; 
2019; Jasanof, 2009; Iannuzzi, 2018; Blume, 2017, Gainotti 
et al., 2008).
EU “Vaccination Roadmap”
An exemplar case in this respect is represented by the EU 
“Vaccination Roadmap”47, a tightly scheduled program star-
46 The recent expulsion from the Cochrane collaboration of Peter 
Gøtzsche in relation to his strong dissent (Jørgensen et al., 2018), 
regarding a meta-analysis on HPV (human papilloma virus) vac-
cines, published by the Cochrane itself, casts shadow not only on 
the reliability of the evidence provided by even the most respected 
institutions, but is also a red flag of the strong pressures these in-
stitutions are subjected to (see also Boem et al., 2020). 
47 https://off-guardian.org/2020/05/22/report-eu-planning-vaccina-
tion-passport-since-2018
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ted in 2018, whose mission is to introduce a “common vacci-
nation card/passport” for all EU citizens by 2022. 
The Vaccination Roadmap is a policy plan to spread vac-
cine “awareness and understanding” whilst counteracting 
“vaccine myths” and combatting “vaccine hesitancy”. Its im-
plementation includes a feasibility study that goes from 2019 
through 2021. (European Commission, 2019). Some of the 
highlights raise several ethical, legal, and political concerns: 
1) Examine the feasibility of developing a common vaccina-
tion card/passport for EU citizens; 2) “Develop EU guidance 
for establishing  comprehensive electronic immunization in-
formation systems for effective monitoring of immunization 
programs.” 3) “overcome the legal and technical barriers 
impeding the interoperability of national immunization in-
formation systems”. Knightly (2020) reports that during the 
joint EU-WHO “Global Vaccination Summit” on September 
2019, a “10 Actions Towards Vaccination for All” plan was 
announced (European Commission and WHO, 2019), and 
a simulated pandemic exercise focusing on a zoonotic novel 
coronavirus originating in bats, Event 20148, was organized 
with the sponsoring of Johns Hopkins Center for Health Se-
curity, the World Economic Forum, and the Bill & Melinda 
Gates Foundation in October 2019. “The point is that pro-
posed COVID countermeasures, which have been presented 
to the public as emergency measures thought up on the fly 
by panicking institutions, have in fact existed since before the 
emergence the disease. They already wanted to monitor your 
vaccination records and tie that to your passport, introduce 
mandatory vaccinations and clampdown on “misinforma-
tion”. They just didn’t have a reason yet. This was a situation 
which required a crisis and, fortuitously, it got one. The exact 
ratio of contrivance to happenstance will never be known” 
(Knightly, 2020). 
Even more disquieting than all this premeditation is the 
fact that, notwithstanding this project constitutes a violation 
of health freedom, and privacy rights, as well as other consti-
tutionally protected rights, it has never been politically scru-
tinized, nor publically discussed. 
European peoples are kept in the dark about such co-
ordinated actions by their legislators in cahoots with agen-
cies and companies holding vested interests of financial and 
other nature. Instead of involving them in a transparent and 
open debate on these programs, they survey the citizens’ opi-
48 https://www.centerforhealthsecurity.org/event201/about. One 
month after this event “a call to action” for “Public-private Coo-
peration for pandemic preparedness and response” was published: 
(The Johns Hopkins Center for Health Security, World Economic 
Forum, and Bill & Melinda Gates Foundation, 2019). “Coinci-
dentally, on December 2019, first covid-19 cases were reported 
from China. What we DO know, at this point, is that SARS-Cov-2 
is nothing like the threat originally reported, they admit as much 
themselves. We also know they keep churning out the fear anyway. 
And, thanks to documents like this, maybe now we’re starting to 
see why” (Knightly, 2020). 
nions on the matter (European Commission, 2018), then de-
sign communication campaigns to increase compliance and 
establish a sort of thought police for dissidents (including 
involuntary psychiatric hold, e.g. TSO in Italy, or 5150 in the 
US); finally, law enforcement follows. As a Nature editorial 
rightly points out, mandatory health treatments are forms 
of juridical systems devoid of a solid democratic tradition: 
“mostly post-Soviet Union states” (Nature, 2018). We would 
suggest, that the EU gaslighting policies in this sense are 
even more unfortunate, in that they put up a brainwashing 
system, with the aim to induce the majority of the popula-
tion to align with the envisaged policies and to even act as a 
whistleblower against incompliant citizens. 
ID 2020
Evidence about the opacity of all this processes is signa-
led by the recent resignation of one of the six members of 
ID2020’s technical advisory committee (Powers, 2020). The 
ID2020 Is a public-private alliance, whose partners include 
Microsoft, Accenture and Hyperledger. According to the 
website, its goal is to develop a global model for the design, 
funding and implementation of digital solutions and techno-
logies. Resignation of the adviser, Elizabeth Renieris, follo-
wed the publication of a white paper, which should have been 
published as Executive Director Dakota Gruener’s exclusi-
ve personal view, and was instead published as an ID2020 
paper. Renieris had raised concerns about security and legal 
issues related to blockchain based digital credentials linked 
to COVID immunity passes, but instead of receiving any re-
sponse on the merit of her queries, the related section was 
dropped altogether. The paper was nevertheless published as 
voicing the official opinion of the entire committee. 
Renieris, founder and CEO of HACKYLAWYER, fel-
low at the Berkman Klein Center for Internet & Society at 
Harvard University, and a Technology & Human Rights fel-
low at the Carr Center for Human Rights Policy at Harvard’s 
Kennedy School of Government, explained her concerns 
in her resignation letter (see Powers, 2020) and in a white 
paper co-authored with privacy and public health experts 
(Renieris et al., 2020): “Despite limited backing from civil 
society or public health experts, as well as warnings from hi-
storians  and  bioethicists, technologists are racing ahead to 
build and deploy digital certificates that would allegedly let 
individuals “prove” whether they have recovered from the 
novel coronavirus disease (COVID-19), have tested positive 
for antibodies, or have received a vaccination, should one be-
come available”. 
Renieris and coauthors insist that such artifacts could 
interfere with our right to privacy, freedoms of association, 
assembly, and movement, our rights to work and education; 
and otherwise seriously limit our freedom and autonomy, 
45BarBara Osimani et al. Science as a weapon of mass distraction (the virus warfare)
even where not compulsory49. After reaffirming that the inter-
ference of digital certificates with such fundamental human 
rights may be justified only in extraordinary circumstances 
and may in no case contravene the established law, the au-
thors go on analyzing whether the “immunity passport” for 
COVID-19 is anything feasible, legal, and ethically legiti-
mate. The passport does not pass any of these tests. From a 
medical perspective, given the scarce knowledge about speci-
ficity and sensitivity of antibody tests, positive results are all 
but a sure fire for discriminating immune from non immune 
subjects, furthermore nothing is known about whether im-
munization against SARS-Cov-2 (either through exposure to 
the virus or vaccination) is permanent or only transitory, or 
whether exposure to the virus confers immunity at all. 
Not only do antibody tests give little guarantee of truly 
identifying immune people; also the development of a vac-
cine for SARS-Cov-2 is all but straightforward. Hence, the 
legitimate question by Renieris et al. (2020): “How could 
partners and stakeholders coalesce around a viable immunity 
certification process, whether paper-based, digital, or other-
wise, amid such uncertainty, a lack of evidence, and paucity 
of tools like reliable diagnostic and antibody tests, or safe 
and effective vaccines on which to anchor immunity status?” 
It also makes no sense from their perspective to refer back 
to the yellow fever international certification of vaccination, 
whose primary function is to “prevent the spread of this di-
sease into non-endemic settings. By contrast, COVID-19 is a 
viral respiratory illness already classified as a pandemic. Im-
munity passports will, in no way, put this particularly terrible 
genie back into the bottle”. The entire project of an “Immu-
nity passport” is also fraught with technical problems that 
branch out into privacy issues, and ethical as well as legal in-
fringements; such as the creation of perverse incentives, risks 
of exclusion and stigmatization, facilitation of potential 
collusion, passive surveillance, and re-identification through 
data inference. They conclude: “The prospect of severely cur-
tailing the fundamental rights and freedoms of individuals 
through ill-thought-out plans for “immunity passports” or 
similar certificates, particularly ones that would leverage 
premature standards and a highly experimental and poten-
tially rights-infringing technology like blockchain, is beyond 
dystopian”. Indeed the development of a global public regi-
stry in connection with immunity classifications has no other 
explanation then the goal to enforce vaccination (Weise, 
2020).
This scenario is a threat to both the scientific enterpri-
se and the survival of democratic societies, since it definitely 
49 “For example, while not expressly mandated by law, individuals 
in post-lockdown China must be able to produce a “green” QR 
code of health status on their mobile device in order to access pu-
blic transportation, enter workplaces or residences, and more, and 
have virtually no way of challenging the automated determination 
of status” (Renieris et al., 2020).
breaches the confidence pact between science and society, as 
well as between citizens and political institutions. Is there a 
way out of this picture?
Discussion: a new Hippocratic Oath
In a recent manifesto (Saltelli et al., 2020), a group of 
epistemologists and scientists warned against the perils of 
“politicians presenting their policies as dictated by science”, 
and political rivals brandishing mathematical models in or-
der to support predetermined agendas and disguise politi-
cal decisions as technical ones. The manifesto pleas for the 
acknowledgment of ignorance following Nicholas of Cusa’s 
emphasis on the “docta ignorantia”: “Spurious precision 
adds to a sense of false certainty. […] Opacity about un-
certainty damages trust […] We are calling not for an end 
to quantification, nor for apolitical models, but for full and 
frank disclosure”. In particular, it is important to emphasize 
asymmetries in acknowledging such scientific uncertainties 
and managing them. 
Although scientific dissent is commonplace, especially 
when dealing with radical uncertainty (Dupuy, 1994; Kay 
and King, 2020), the COVID-19 emergency let come to the 
sunlight how uncertainty may be downplayed or stressed de-
pending on specific agendas. 
However, suspicions about the possible conflicts of in-
terest affecting the scientific enterprise, and the system of 
incentives characterizing the ecosystem in which scientific 
activities and practices are embedded lead in turn to a loss of 
trust in, and in the policy maker.
In particular, the COVID-19 gloomy scenario reveals to 
be the effect of a deadly mix of malicious incentives. The IT 
companies interest in further increasing the implementation 
of digital technologies in every area of our life, the pharma-
ceutical industry’s interest in mass vaccination, and related 
regulatory capture, the legislator concern over the increasing 
welfare expenditures, hospitals incentives to intubate people 
rather than curing them in the earlier phases of the disease, 
etc. 
Several doctors, scientists and politicians are raising their 
voices against this setup: the AMPAS public notice mentio-
ned above, an open letter sent to the Premier Minister and 
other Health Authorities by a group of concerned doctors 
(Bacco et al., 2020), the testimonies of nurses and the inter-
views to scientists cited in this paper, the activism of several 
public figures, among whom most prominently Robert Ken-
nedy Jr. and his Foundation “Children’s Health Defense”, all 
testify that there is increasing awareness over the bleak pro-
spect of a technocratic society. This gives hope that energies 
can be joint in order to counteract such destructive forces. 
Science is increasingly perceived as a “credence good” 
(Akerlof, 1978, Osimani et al., forthcoming). Consequen-
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tly, opinions do not only diverge among scientists, but also 
regarding science policy approaches, e.g. regarding the best 
institutional and market-based mechanisms to be used to 
design the bio-pharma ecosystem, comprising universities 
and research centers, knowledge-intensive corporate sectors, 
public and private health-care providers, NGOs, associations 
and citizens. 
This paper cannot tackle these questions systematically, 
but we advance some proposals. First, doctors should deci-
de whose side to stay, and take action. As also the AMPAS 
letter emphasizes, prevention should be given a much more 
prominent role in Medicine and patients should be defended 
from medicalization. Doctors should be a stronger barrier 
between the industry greed and the people’s health and well-
being. A preventive approach would have obvious beneficial 
repercussions also on the State expenditures for the health 
care system.
The responsible authorities should consequently develop 
virtuous mechanisms that reward overall public and indivi-
dual health, instead of just reimbursing interventions (with 
the consequent spiral of increasing insurance costs). 
Experts should be involved in a transparent and non-de-
legating manner. Experts should bring their contribution in 
the democratically elected Parliament, who should then deci-
de on the basis of such contribution and in considerations of 
non-scientific issues, such as ethical, economic, religious and 
legal desiderata. Otherwise experts just become an excuse to 
sidestep democratic procedures.
As Tallacchini (2019) underlines, authoritarianism and 
nudging are not the only possible routes to be explored. A 
third way is a new confidence pact between institutions, pri-
vate sector and citizens, and a new Hippocratic oath between 
patients and doctors, fostered by the right mechanisms, both 
for the social planner and for the entrepreneur, in view of the 
long term wellbeing and welfare of the population. If  someo-
ne needs to be nudged, this is those who hold the power in the 
system of asymmetries characterizing complex societies, not 
the vulnerable, whom the State should defend from abuses of 
power, of any kind.
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